Back to top

ASND Maintained by RBC Capital -- Price Target Raised to $280

ASND Maintained by RBC Capital -- Price Target Raised to $280

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ascendis Pharma A/S (ASND)